NASDAQ:UNCY

Unicycive Therapeutics Stock Insider Trading

etoro logo Buy UNCY
*Your capital is at risk
$7.87
+1.02 (+14.89%)
At Close: Jun 22, 2026

Unicycive Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.60. In total, the insiders bought 161.89M and sold 2.93M UNCY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.60
Buy 161.89M shares
Sell 2.93M shares
92% Buy Activity
Weak Positive Correlation
Buy Signal High Confidence
May 14, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 99.6.
  • Confidence increased due to high data reliability score of 90.
  • Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date Type Person Role Amount
Sep 05, 2023
Buy
Stock Options
A-Award
Laumas Sandeep
Director
Director 189 236
Value: $143.8K
Sep 05, 2023
Buy
Stock Options
A-Award
Kenkare-mitra Sara
Director
Director 180 000
Value: $136.8K
Sep 05, 2023
Buy
Stock Options
A-Award
Ryan John L
Director
Director 112 147
Value: $85.2K
Sep 05, 2023
Buy
Stock Options
A-Award
Aggarwal Gaurav
Director
Director 180 000
Value: $136.8K
Sep 05, 2023
Buy
Common Stock
J-Other
Kenkare-mitra Sara
Director 0
Value: $0
Sep 05, 2023
Buy
Stock Options
A-Award
Laumas Sandeep
Director
Director 189 236
Value: $143.8K
Sep 05, 2023
Buy
Stock Options
A-Award
Kenkare-mitra Sara
Director
Director 180 000
Value: $136.8K
Sep 05, 2023
Buy
Stock Options
A-Award
Ryan John L
Director
Director 112 147
Value: $85.2K
Sep 05, 2023
Buy
Stock Options
A-Award
Aggarwal Gaurav
Director
Director 180 000
Value: $136.8K
Sep 05, 2023
Buy
Common Stock
J-Other
Kenkare-mitra Sara
Director 0
Value: $0
Aug 28, 2023
Buy
Stock Options
A-Award
Gupta Pramod
EVP, Pharmaceuticals And Bd
Officer 1 355 000
Value: $1.02M
Aug 28, 2023
Buy
Stock Options
A-Award
Gupta Shalabh K.
CEO
CEO / President 4 684 775
Value: $3.51M
Aug 28, 2023
Buy
Stock Options
A-Award
Townsend John
Chief Financial Officer
C-Suite Officer 570 329
Value: $427.7K
Aug 28, 2023
Buy
Stock Options
A-Award
Jermasek Douglas
EVP Of Corporate Strategy
Officer 1 355 000
Value: $1.02M
Aug 28, 2023
Buy
Stock Options
A-Award
Gupta Pramod
EVP, Pharmaceuticals And Bd
Officer 1 355 000
Value: $1.02M
Aug 28, 2023
Buy
Stock Options
A-Award
Gupta Shalabh K.
CEO
CEO / President 4 684 775
Value: $3.51M
Aug 28, 2023
Buy
Stock Options
A-Award
Townsend John
Chief Financial Officer
C-Suite Officer 570 329
Value: $427.7K
Aug 28, 2023
Buy
Stock Options
A-Award
Jermasek Douglas
EVP Of Corporate Strategy
Officer 1 355 000
Value: $1.02M
Jul 11, 2023
Buy
Tranche C Warrants (right to buy)
C-Conversion
Aggarwal Gaurav
Director
Director 18 621 655
Value: $13.8M
Jul 11, 2023
Buy
Series A-2 Preferred Stock
C-Conversion
Aggarwal Gaurav
Director
Director 13 429 000
Value: $0
Jul 11, 2023
Buy
Tranche A Warrants (right to buy)
C-Conversion
Aggarwal Gaurav
Director
Director 12 802 388
Value: $6.90M
Jul 11, 2023
Buy
Tranche B Warrants (right to buy)
C-Conversion
Aggarwal Gaurav
Director
Director 11 638 534
Value: $6.90M
Jul 11, 2023
Buy
Common Stock
C-Conversion
Aggarwal Gaurav
Director
Director 3 470 152
Value: $0
Jul 11, 2023
Sell
Series A-1 Preferred Stock
C-Conversion
Aggarwal Gaurav
Director
Director 8 077
Value: $4K
Jul 11, 2023
Buy
Common Stock
M-Exempt
Jermasek Douglas
EVP Of Corporate Strategy
Officer 104 612
Value: $51.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT UNICYCIVE THERAPEUTICS, INC.
Unicycive Therapeutics
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California....
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE